Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


VaxInnate Corporation

VaxInnate is developing novel, proprietary vaccines for pandemic and seasonal influenza. Using a proven technology platform, VaxInnate has the potential to produce potent vaccines for a range of infectious diseases and help meet urgent public health needs.

Search Projects

  • Chief Executive Officer
  • Head, Regulatory Affairs
  • Board Member